MAGEA3 and cancer: On the contrary, intra-molecular diversification of the T-cell response reported for self-antigens such as MAGE Family Member A3 (MAGEA3) (16) or Telomerase (TERT) (17) provided stronger evidence that a true break of immune tolerance occurred in the few patients successfully reacting to cancer vaccines.